Compare CLDX & TIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CLDX | TIC |
|---|---|---|
| Founded | N/A | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.0B |
| IPO Year | 2008 | N/A |
| Metric | CLDX | TIC |
|---|---|---|
| Price | $25.87 | $10.38 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 3 |
| Target Price | ★ $44.10 | $14.17 |
| AVG Volume (30 Days) | 718.4K | ★ 2.5M |
| Earning Date | 11-10-2025 | 02-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $2,599,000.00 | ★ $1,284,070,000.00 |
| Revenue This Year | N/A | $41.97 |
| Revenue Next Year | $19.70 | $42.94 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 16.15 |
| 52 Week Low | $14.40 | $8.76 |
| 52 Week High | $30.50 | $14.94 |
| Indicator | CLDX | TIC |
|---|---|---|
| Relative Strength Index (RSI) | 44.96 | 50.99 |
| Support Level | $24.97 | $10.12 |
| Resistance Level | $28.79 | $10.59 |
| Average True Range (ATR) | 1.36 | 0.44 |
| MACD | -0.36 | 0.15 |
| Stochastic Oscillator | 16.46 | 49.66 |
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
TIC Solutions Inc is a provider of tech-enabled Testing, Inspection, Certification and Compliance (TICC), engineering, and geospatial services. It provides mission-critical services that are essential to the safety, reliability, and efficiency of industrial assets, buildings and public infrastructure. The company's services are often non-discretionary and are driven by regulatory requirements, customer risk management policies, and the need to extend the useful life of critical assets. It operates in North America and serve both public- and private-sector clients. Its public-sector clients include federal, state, and municipal agencies, public utilities, and environmental regulators. Its private-sector clients span industrial, infrastructure, construction, and real estate end markets.